US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Fidelity Disruptive Medicine ETF

31.93

+0.36781.17%

Volume:3K

Turnover:104.17K

Market Cap:51.84M

PE:- -

High:32.23

Open:31.63

Low:31.63

Close:31.56

52wk High:32.89

52wk Low:23.48

Shares:1.62M

Float Shares:1.62M

Volume Ratio:0.52

T/O Rate:0.20%

Dividend:- -

Dividend Rate:- -

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

10x Genomics (TXG) Stock Looks Fully Priced As Atera Demand Lifts Guidance

Simply Wall St.

Argenx Se (ARGX) Receives a Buy from Citi

Why LifeStance Health Group (LFST) Is Up 5.5% After Profitable Quarter, Higher Guidance And New Buyback

Simply Wall St.

Argenx Se : TD Cowen Raises Target Price to $1353 from $1146

THOMSON REUTERS

Argenx Se : Truist Securities Raises Target Price to $1095 from $1030

THOMSON REUTERS

Steris PLC Stock Underperforms Monday When Compared to Competitors

ADRs Close Higher; Argenx SE Climbs 16%

10x Genomics Director Sarah A. Teichmann Disposes of USD 433,106 in Common Shares

William Blair says Argenx’s ALKIVIA results boost confidence in Vyvgart DM path

Argenx Stock Heads for Record After Blockbuster Drug Delivers Another Win

argenx SE Stock (ARGX) Moved Up by 16.67% on Aug 17: Drivers Behind the Movement

Argenx Price Target Raised to $1215.00/Share from $1075.00 by Piper Sandler

European Equities Traded in the US as American Depositary Receipts Open Week Higher in Monday Trading

MT Newswires Live

Wedbush Adjusts Argenx PT to $1,150 From $1,050, Maintains Outperform Rating

MT Newswires Live

Argenx SE (ARGX) Stock Soars 15% on Positive Phase 3 Study Results

Argenx SE up over 15%, on Pace for Largest Percent Increase Since July 2023

Argenx rises 14.9%

Sector Update: Healthcare

MT Newswires Live

Argenx price target raised to $1,215 from $1,075 at Piper Sandler

argenx Says Autoimmune Myositis Drug Meets Main Goal in Phase 3 Study

MT Newswires Live

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg.tigeractivity.com/stock/FMED/news?page=4"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"FMED","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"FMED\",,,,,undefined,":{"symbol":"FMED","market":"US","secType":"STK","nameCN":"Fidelity Disruptive Medicine ETF","latestPrice":31.925,"timestamp":1788376769282,"preClose":31.5572,"halted":0,"volume":3267,"delay":0,"changeRate":0.01165502642820019,"floatShares":1623806,"shares":1623806,"eps":0,"marketStatus":"Trading","change":0.3678,"latestTime":"09-02 15:30:12 EDT","open":31.63,"high":32.23,"low":31.63,"amount":104165.870886,"amplitude":0.019013,"askPrice":31.96,"askSize":500,"bidPrice":31.91,"bidSize":71,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1788379200000},"marketStatusCode":2,"adr":0,"exchange":"NASDAQ","adjPreClose":31.5572,"sharesOutstanding":2323806,"nav":31.741048,"aum":51541304.188688,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":31.54,"preClose":31.5572,"latestTime":"19:30 EDT","volume":9,"amount":284.9004,"timestamp":1788305405892,"change":-0.0172,"changeRate":-0.000545,"amplitude":0},"volumeRatio":0.522896,"impliedVol":0.0806,"impliedVolPercentile":0.2543},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"FMED\",,,,,undefined,":{"symbol":"FMED","floatShares":1623806,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.522896,"shares":1623806,"dividePrice":0,"high":32.23,"amplitude":0.019013,"preClose":31.5572,"low":31.63,"week52Low":23.48,"pbRate":"--","week52High":32.8877,"institutionHeld":0,"latestPrice":31.925,"committee":-0.751313,"eps":0,"divideRate":0,"volume":3267,"delay":0,"ttmEps":0,"open":31.63,"prevYearClose":27.05,"prevWeekClose":31.6372,"prevMonthClose":31.775,"prevQuarterClose":28.525,"fiveDayClose":32.4944,"twentyDayClose":28.8396,"sixtyDayClose":24.385},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/FMED\",params:#limit:5,,,undefined,":[{"date":"2024-12-20","symbol":"FMED","amount":0.112,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-12-20","defaultRemindTime":1734705000000,"name":"Fidelity Disruptive Medicine ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-12-24","payableDate":"2024-12-20","currency":"USD","dateTimestamp":1734670800000,"payDate":"2024-12-24"},{"date":"2024-06-21","symbol":"FMED","amount":0.001,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-06-21","defaultRemindTime":1718976600000,"name":"Fidelity Disruptive Medicine ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-06-25","payableDate":"2024-06-21","currency":"USD","dateTimestamp":1718942400000,"payDate":"2024-06-25"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"FMED\",market:\"US\",,,undefined,":[{"executeDate":"2024-06-21","recordDate":"2024-06-21","paymentDate":"2024-06-25","value":0.001,"currency":"USD"},{"executeDate":"2024-12-20","recordDate":"2024-12-20","paymentDate":"2024-12-24","value":0.112,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"FMED\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"FMED\",pageSize:20,pageCount:4,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2660469194","title":"10x Genomics (TXG) Stock Looks Fully Priced As Atera Demand Lifts Guidance","url":"https://stock-news.laohu8.com/highlight/detail?id=2660469194","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660469194?lang=en_us&edition=fundamental","pubTime":"2026-08-18 17:25","pubTimestamp":1787045146,"startTime":"0","endTime":"0","summary":"10x Genomics stock has delivered a very strong 330.8% return over the past year, yet the current valuation checks lean expensive rather than pointing to an obvious bargain.\n\nThe 330.8% gain over 12 months highlights how quickly expectations have shifted for 10x Genomics, which raises the bar for what the business now needs to deliver.\nStronger interest in the Atera spatial biology platform and related partnerships can support higher revenue expectations, while any slowdown in that demand or...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/9551728-choice1-main-header/1585186657000","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9551728-choice1-main-header/1585186657000"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-txg/10x-genomics/news/10x-genomics-txg-stock-looks-fully-priced-as-atera-demand-li","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-txg/10x-genomics/news/10x-genomics-txg-stock-looks-fully-priced-as-atera-demand-li","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4548","BK4121","LU1861559042.SGD","BK4588","ARKG","LU0963586101.USD","LU1861558580.USD","TXG","BK4585","FMED"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660457633","title":"Argenx Se (ARGX) Receives a Buy from Citi","url":"https://stock-news.laohu8.com/highlight/detail?id=2660457633","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660457633?lang=en_us&edition=fundamental","pubTime":"2026-08-18 14:55","pubTimestamp":1787036118,"startTime":"0","endTime":"0","summary":"In a report released today, Samantha Semenkow from Citi maintained a Buy rating on Argenx Se, with a price target of $1,301.00. According to TipRan...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/argenx-se-argx-receives-a-buy-from-citi-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/argenx-se-argx-receives-a-buy-from-citi-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ARGX","BK4505","FMED","IE0002141913.USD","IBB","IE00BJT1NW94.SGD","BK4139","IE00BFTCPJ56.SGD","IE0009355771.USD","BK4585","IE00B2B36J28.USD","LU0823416689.USD","IE0034235188.USD","LU0320765992.SGD","LU0889565916.HKD","BK4588","IE00B4R5TH58.HKD","IE00BJJMRZ35.SGD","LU2324357040.USD","LU0109394709.USD","LU1983260115.SGD","TBXU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660452322","title":"Why LifeStance Health Group (LFST) Is Up 5.5% After Profitable Quarter, Higher Guidance And New Buyback","url":"https://stock-news.laohu8.com/highlight/detail?id=2660452322","media":"Simply Wall St.","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660452322?lang=en_us&edition=fundamental","pubTime":"2026-08-18 13:21","pubTimestamp":1787030492,"startTime":"0","endTime":"0","summary":"In the second quarter of 2026, LifeStance Health Group, Inc. reported revenue of US$435.35 million and net income of US$23.61 million, turned around from a net loss a year earlier, and completed a US$97.19 million share repurchase program under its February 2026 authorization while also announcing a new up to US$100 million buyback.\nThe company also raised its full-year 2026 revenue outlook to a range of US$1.69 billion to US$1.73 billion, signaling management’s confidence alongside this...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6032000-choice1-main-header/1585186661957","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6032000-choice1-main-header/1585186661957"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nasdaq-lfst/lifestance-health-group/news/why-lifestance-health-group-lfst-is-up-55-after-profitable-q","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/healthcare/nasdaq-lfst/lifestance-health-group/news/why-lifestance-health-group-lfst-is-up-55-after-profitable-q","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LFST","AIPO","FMED","BK4535","BK4196","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660451398","title":"Argenx Se : TD Cowen Raises Target Price to $1353 from $1146","url":"https://stock-news.laohu8.com/highlight/detail?id=2660451398","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660451398?lang=en_us&edition=fundamental","pubTime":"2026-08-18 12:16","pubTimestamp":1787026573,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260818:nFWN44E0RL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IE00B4R5TH58.HKD","IE0034235188.USD","IE00BJJMRZ35.SGD","FMED","LU0823416689.USD","IBB","IE0002141913.USD","IE00B2B36J28.USD","BK4505","LU0109394709.USD","LU0889565916.HKD","LU2324357040.USD","BK4588","LU0320765992.SGD","IE0009355771.USD","TBXU","IE00BJT1NW94.SGD","BK4585","IE00BFTCPJ56.SGD","ARGX","LU1983260115.SGD","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660456165","title":"Argenx Se : Truist Securities Raises Target Price to $1095 from $1030","url":"https://stock-news.laohu8.com/highlight/detail?id=2660456165","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660456165?lang=en_us&edition=fundamental","pubTime":"2026-08-18 10:39","pubTimestamp":1787020796,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260818:nFWN44E0QM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4585","LU1983260115.SGD","FMED","BK4588","IE00B2B36J28.USD","BK4505","ARGX","IE0002141913.USD","IE00BFTCPJ56.SGD","BK4139","IE00BJJMRZ35.SGD","IE00BJT1NW94.SGD","LU0320765992.SGD","IE0009355771.USD","IBB","LU2324357040.USD","IE0034235188.USD","TBXU","LU0889565916.HKD","LU0823416689.USD","LU0109394709.USD","IE00B4R5TH58.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660243207","title":"Steris PLC Stock Underperforms Monday When Compared to Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2660243207","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660243207?lang=en_us&edition=fundamental","pubTime":"2026-08-18 05:07","pubTimestamp":1787000820,"startTime":"0","endTime":"0","summary":"DJ Steris PLC Stock Underperforms Monday When Compared To CompetitorsThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Steris PLC  slid 1.51% to $229.75 Monday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index  falling 0.52% to 7,745.06 and Dow Jones Industrial Average  falling 0.51% to 53,459.78.This was the stock's fifth consecutive day of losses.Steris PLC closed 14.73% below its 52-week high of $269.44, which the company reached on January 16th.The stock underperformed when compared to some of its competitors Monday, as Thermo Fisher Scientific Inc.  fell 0.47% to $585.51, Danaher Corp.  rose 0.09% to $202.63, and Becton Dickinson & Co.  fell 0.71% to $182.09.Trading volume  remained 138,976 below its 50-day average volume of 807,197.Data source: Dow Jones Market Data, FactSet. Data compiled August 17, 2026.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1670628061.USD","LU2211815571.USD","LU1064131342.USD","LU0109391861.USD","TMED","TMO","LU0128525929.USD","IE00BFXG1179.USD","DHR","LU0345770308.USD","LU2764263039.SGD","LU0943347566.SGD","LU0124676726.USD","IE00B1BXHZ80.USD","LU0345770993.USD","BK4533","LU0072461881.USD","LU0070302665.USD","LU0477156797.USD","LU2106854487.HKD","HRTS","LU1989771016.USD","LU1923622291.USD","LU0006061336.USD","LU1059921491.USD","IE00BZ1G4Q59.USD","FMED","LU2041044095.USD","BK4121","SGXZ23171101.USD","LU0289739343.SGD","BK4566","LU0057025933.USD","BK4581","LU2063271972.USD","LU0432979614.USD","GNMX","LU1291159041.SGD","BDX","IHI","LU1150488135.SGD","LU2023250504.SGD","LU0648000940.SGD","LU1267930573.SGD","LU1720051017.SGD","LU0878866978.SGD","IE0034235188.USD","LU0208291251.USD","STE","LU0820561909.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660432656","title":"ADRs Close Higher; Argenx SE Climbs 16%","url":"https://stock-news.laohu8.com/highlight/detail?id=2660432656","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660432656?lang=en_us&edition=fundamental","pubTime":"2026-08-18 04:31","pubTimestamp":1786998660,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.International stocks trading in New York closed higher on Monday, as the S&P/BNY Mellon index of American","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B4R5TH58.HKD","IE0034235188.USD","IE00BJJMRZ35.SGD","FMED","LU0823416689.USD","SCHY","IBB","IE0002141913.USD","IE00B2B36J28.USD","BK4505","LU0109394709.USD","LU0889565916.HKD","LU2324357040.USD","BK4588","LU0320765992.SGD","IE0009355771.USD","TBXU","IE00BJT1NW94.SGD","BK4585","IE00BFTCPJ56.SGD","ARGX","LU1983260115.SGD","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660434081","title":"10x Genomics Director Sarah A. Teichmann Disposes of USD 433,106 in Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2660434081","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660434081?lang=en_us&edition=fundamental","pubTime":"2026-08-18 04:09","pubTimestamp":1786997366,"startTime":"0","endTime":"0","summary":"10x Genomics director Sarah A. Teichmann disposes of USD 433,106 in common shares10x Genomics director Sarah A. Teichmann sold 7,551 Class A common shares on Aug. 13-14.Sales priced at $57.29 and $57.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260817:nNDL9D8HHJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"10x Genomics Director Sarah A. Teichmann Disposes of USD 433,106 in Common Shares","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","BK4588","LU1861558580.USD","LU1861559042.SGD","ARKG","FMED","BK4548","TXG","BK4121"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660888434","title":"William Blair says Argenx’s ALKIVIA results boost confidence in Vyvgart DM path","url":"https://stock-news.laohu8.com/highlight/detail?id=2660888434","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660888434?lang=en_us&edition=fundamental","pubTime":"2026-08-18 02:20","pubTimestamp":1786990827,"startTime":"0","endTime":"0","summary":"William Blair notes that Argenx (ARGX) announced top-line results from the Phase III ALKIVIA trial of Vyvgart in autoimmune myositis, showing a cli...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/william-blair-says-argenxs-alkivia-results-boost-confidence-in-vyvgart-dm-path-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/william-blair-says-argenxs-alkivia-results-boost-confidence-in-vyvgart-dm-path-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE0034235188.USD","IE0002141913.USD","IE00BJT1NW94.SGD","IE0009355771.USD","IE00BFTCPJ56.SGD","BK4139","IE00BJJMRZ35.SGD","BK4588","ARGX","TBXU","LU2324357040.USD","IE00B2B36J28.USD","IE00B4R5TH58.HKD","LU0109394709.USD","IBB","FMED","LU1983260115.SGD","BK4585","LU0823416689.USD","LU0320765992.SGD","LU0889565916.HKD","BK4505"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660431479","title":"Argenx Stock Heads for Record After Blockbuster Drug Delivers Another Win","url":"https://stock-news.laohu8.com/highlight/detail?id=2660431479","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660431479?lang=en_us&edition=fundamental","pubTime":"2026-08-18 02:04","pubTimestamp":1786989840,"startTime":"0","endTime":"0","summary":"Argenx's autoimmune drug Vyvgart achieved blockbuster status in just its second full year on the market. Now, the Dutch biotech is looking to expand use of the drug to treat more conditions.Argenx on ","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0109394709.USD","BK4139","IE00B2B36J28.USD","LU0823416689.USD","BK4585","ARGX","LU2324357040.USD","IE0009355771.USD","IBB","LU0889565916.HKD","IE0002141913.USD","IE00BFTCPJ56.SGD","IE00BJT1NW94.SGD","BK4588","TBXU","FMED","IE00B4R5TH58.HKD","IE00BJJMRZ35.SGD","IE0034235188.USD","BK4505","LU1983260115.SGD","LU0320765992.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660650439","title":"argenx SE Stock (ARGX) Moved Up by 16.67% on Aug 17: Drivers Behind the Movement","url":"https://stock-news.laohu8.com/highlight/detail?id=2660650439","media":"TradingKey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660650439?lang=en_us&edition=fundamental","pubTime":"2026-08-18 00:15","pubTimestamp":1786983324,"startTime":"0","endTime":"0","summary":"• Argenx announced positive Phase 3 ALKIVIA study results for VYVGART Hytrulo in myositis.\n• The company reported $4.15 billion in annual revenue and $1.29 billion in net profit.\n• Analysts issued Buy ratings with an average price target of $1083.77.","market":"sh","thumbnail":"https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg","type":0,"news_type":0,"thumbnails":["https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tradingkey.com/news/market-movers/262112694-market-movers-argx-20260817","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","LU0109394709.USD","BK4139","IE0034235188.USD","LU0320765992.SGD","ARGX","IE00B4R5TH58.HKD","IE00BJT1NW94.SGD","IE0002141913.USD","IE00B2B36J28.USD","TBXU","LU0889565916.HKD","LU0823416689.USD","IE00BFTCPJ56.SGD","IE00BJJMRZ35.SGD","LU2324357040.USD","IE0009355771.USD","FMED","LU1983260115.SGD","BK4505","BK4585","IBB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660439344","title":"Argenx Price Target Raised to $1215.00/Share from $1075.00 by Piper Sandler","url":"https://stock-news.laohu8.com/highlight/detail?id=2660439344","media":"Dow Jones","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660439344?lang=en_us&edition=fundamental","pubTime":"2026-08-18 00:07","pubTimestamp":1786982820,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/ARGX/analyst-ratings","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TBXU","IE00BFTCPJ56.SGD","IE00B4R5TH58.HKD","BK4588","IE0002141913.USD","BK4505","LU0823416689.USD","LU0320765992.SGD","LU1983260115.SGD","BK4139","IE0034235188.USD","IBB","IE00BJJMRZ35.SGD","LU2324357040.USD","ARGX","IE0009355771.USD","LU0889565916.HKD","FMED","LU0109394709.USD","IE00BJT1NW94.SGD","IE00B2B36J28.USD","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660323436","title":"European Equities Traded in the US as American Depositary Receipts Open Week Higher in Monday Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2660323436","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660323436?lang=en_us&edition=fundamental","pubTime":"2026-08-17 23:12","pubTimestamp":1786979555,"startTime":"0","endTime":"0","summary":"European equities traded in the US as American depositary receipts started the week tracking modestly higher late Monday morning, rising 0.31% to 1,970.56 on the S&P Europe Select ADR Index.From continental Europe, the gainers were led by biopharmaceutical companies argenx  and DBV Technologies , which climbed 16% and 5.1% respectively. They were followed by telecommunications company Nokia  and biopharmaceutical company Cellectis , which advanced 2.5% and 2% respectively.The decliners from continental Europe were led by medical device maker EDAP TMS  and internet browser company Opera , which dropped 4.6% and 2.7% respectively. They were followed by brewing company Anheuser-Busch InBev  and consumer goods company Unilever , which lost 2.4% and 1.6% respectively.The gainers from the UK were led by biotech firm Autolus Therapeutics  and biopharmaceutical company Akari Therapeutics , which rose 6.3% and 2.8% respectively. They were followed by biopharmaceutical companies GSK  and Bicycle","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IEUR","BUD","DEO","AFG","GSK","LFGY","EPV","TBXU","BK4009","WPP","BK4588","LU0006061336.USD","BK4007","IE00BMPRXN33.USD","IE00BJJMRZ35.SGD","IE00BFTCPJ56.SGD","DBVT","DGE.UK","NCNA","LU1983260115.SGD","BUD.AU","IBB","BK4169","AUTL","FMED","LU0889565916.HKD","MREO","UL","NOK","LNOK","BCYC","OPRA","IE00B4R5TH58.HKD","ARGX","BK4592","BK4117","BK4139","IE0002141913.USD","LU0823416689.USD","WPP.AU","BK4505","CLLS","BK4107","UN","FOCL","GSKH","ULVR.UK","BK4532","GSK.UK","AKTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660543552","title":"Wedbush Adjusts Argenx PT to $1,150 From $1,050, Maintains Outperform Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2660543552","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660543552?lang=en_us&edition=fundamental","pubTime":"2026-08-17 22:35","pubTimestamp":1786977309,"startTime":"0","endTime":"0","summary":"Argenx (ARGX) has an average rating of buy and mean price target of $1,094.70, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major banks and","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IE00BJJMRZ35.SGD","LU0109394709.USD","IE0002141913.USD","LU0320765992.SGD","IBB","IE0009355771.USD","IE00BJT1NW94.SGD","LU0823416689.USD","BK4585","IE00B2B36J28.USD","LU0889565916.HKD","BK4505","IE00BFTCPJ56.SGD","BK4588","IE0034235188.USD","BK4139","TBXU","FMED","LU1983260115.SGD","IE00B4R5TH58.HKD","ARGX","LU2324357040.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660433030","title":"Argenx SE (ARGX) Stock Soars 15% on Positive Phase 3 Study Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2660433030","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660433030?lang=en_us&edition=fundamental","pubTime":"2026-08-17 22:11","pubTimestamp":1786975871,"startTime":"0","endTime":"0","summary":"Argenx SE stock was up 15.25% on Monday after the company posted results from its ALKIVIA Phase 3 study.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/argenx-se-argx-stock-soars-15-on-positive-phase-3-study-results?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/argenx-se-argx-stock-soars-15-on-positive-phase-3-study-results?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["FMED","ARGX","TBXU","LU1983260115.SGD","LU0320765992.SGD","IE0009355771.USD","IE00BFTCPJ56.SGD","BK4139","IE00B2B36J28.USD","IE0034235188.USD","LU0889565916.HKD","IE00BJT1NW94.SGD","BK4505","IBB","LU0109394709.USD","LU2324357040.USD","IE0002141913.USD","IE00BJJMRZ35.SGD","BK4585","LU0823416689.USD","BK4588","IE00B4R5TH58.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660433417","title":"Argenx SE up over 15%, on Pace for Largest Percent Increase Since July 2023","url":"https://stock-news.laohu8.com/highlight/detail?id=2660433417","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660433417?lang=en_us&edition=fundamental","pubTime":"2026-08-17 22:08","pubTimestamp":1786975680,"startTime":"0","endTime":"0","summary":"argenx SE Sponsored ADR  is currently at $979.54, up $128.25 or 15.07%--Would be new all-time closing high --Would be the first record close since July 2, 2026, when it closed at $939.68--On pace for largest percent increase since July 17, 2023, when it rose 27.79%--Snaps a two day losing streak--Up 14.72% month-to-date--Up 16.48% year-to-date--Up 48.12% from 52 weeks ago , when it closed at $661.32--Would be a new 52-week closing high--Up 49.12% from its 52-week closing low of $656.89 on Aug. 19, 2025--Traded as high as $982.95; new all-time intraday high --Up 15.47% at today's intraday high; largest intraday percent increase since July 17, 2023, when it rose as much as 31.54%All data as of 10:02:39 AM ETSource: Dow Jones Market Data, FactSet","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BJT1NW94.SGD","IE00BJJMRZ35.SGD","IE00BFTCPJ56.SGD","IE0002141913.USD","FMED","IE0009355771.USD","TBXU","LU0889565916.HKD","BK4505","IE0034235188.USD","LU2324357040.USD","BK4588","BK4585","ARGX","IBB","LU0320765992.SGD","BK4139","IE00B2B36J28.USD","LU0109394709.USD","LU0823416689.USD","IE00B4R5TH58.HKD","LU1983260115.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660743398","title":"Argenx rises 14.9%","url":"https://stock-news.laohu8.com/highlight/detail?id=2660743398","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660743398?lang=en_us&edition=fundamental","pubTime":"2026-08-17 22:00","pubTimestamp":1786975211,"startTime":"0","endTime":"0","summary":"Argenx (ARGX) is up 14.9%, or $126.60 to $977.89. Published first on TheFly – the ultimate source for real-time, market-moving breaking financial n...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/argenx-rises-14-9-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/argenx-rises-14-9-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0889565916.HKD","IE00B4R5TH58.HKD","LU0109394709.USD","IE0034235188.USD","LU0823416689.USD","BK4588","LU2324357040.USD","IBB","BK4139","IE00BJJMRZ35.SGD","IE00B2B36J28.USD","BK4585","IE00BJT1NW94.SGD","FMED","IE00BFTCPJ56.SGD","IE0002141913.USD","TBXU","LU0320765992.SGD","BK4505","ARGX","IE0009355771.USD","LU1983260115.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660480066","title":"Sector Update: Healthcare","url":"https://stock-news.laohu8.com/highlight/detail?id=2660480066","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660480066?lang=en_us&edition=fundamental","pubTime":"2026-08-17 21:04","pubTimestamp":1786971840,"startTime":"0","endTime":"0","summary":"Healthcare stocks were mixed premarket Monday, with the State Street Health Care Select Sector SPDR ETF  0.5% lower and the iShares Biotechnology ETF  up 0.2%.Argenx  shares were nearly 12% higher after the company said a phase 3 study evaluating its experimental drug, Vyvgart Hytrulo, in adults with autoimmune myositis met its main goal.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["FDN","IE00BJJMRZ35.SGD","FMED","IE00B4R5TH58.HKD","LU1883839398.USD","LABU","LU0823416689.USD","IBB","BK4585","STT","LU0061475181.USD","IE0034235188.USD","HCSG","BK4581","XBI","LU2324357040.USD","BK4550","XLV","LU0109394709.USD","ARGX","BK4588","IE00BJT1NW94.SGD","IE00B64PRP62.GBP","BK4137","IE0002141913.USD","BK4139","IE00BGHQF748.EUR","LU0128526141.USD","LU1894683348.USD","IE0009355771.USD","LU1983260115.SGD","IE00B2B36J28.USD","LU0029874061.USD","IE00BFTCPJ56.SGD","BK4135","BK4505","TBXU","LU1894683264.USD","LU0889565916.HKD","IE00B3QW5Z07.USD","LU0320765992.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660484769","title":"Argenx price target raised to $1,215 from $1,075 at Piper Sandler","url":"https://stock-news.laohu8.com/highlight/detail?id=2660484769","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660484769?lang=en_us&edition=fundamental","pubTime":"2026-08-17 19:13","pubTimestamp":1786965211,"startTime":"0","endTime":"0","summary":"Piper Sandler raised the firm’s price target on Argenx (ARGX) to $1,215 from $1,075 and keeps an Overweight rating on the shares. With Q2 2026 repo...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/argenx-price-target-raised-to-1215-from-1075-at-piper-sandler-thefly-news-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/argenx-price-target-raised-to-1215-from-1075-at-piper-sandler-thefly-news-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TBXU","IE0034235188.USD","IE00BFTCPJ56.SGD","IE00BJT1NW94.SGD","LU0109394709.USD","LU0823416689.USD","FMED","LU1983260115.SGD","IE0009355771.USD","BK4585","BK4588","IE00B2B36J28.USD","LU2324357040.USD","IE00B4R5TH58.HKD","LU0320765992.SGD","BK4139","BK4505","IBB","IE00BJJMRZ35.SGD","IE0002141913.USD","ARGX","LU0889565916.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660483685","title":"argenx Says Autoimmune Myositis Drug Meets Main Goal in Phase 3 Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2660483685","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660483685?lang=en_us&edition=fundamental","pubTime":"2026-08-17 16:25","pubTimestamp":1786955131,"startTime":"0","endTime":"0","summary":"argenx  said a phase 3 study evaluating its experimental drug, Vyvgart Hytrulo, in adults with autoimmune myositis met main goal.The company said the patients treated with the drug showed a statistically significant improvement in mean total improvement score at week 52 compared with placebo.Treatment benefits emerged as early as week 4 and were sustained through the 52-week treatment period, including during steroid tapering, the company said.argenx said the primary endpoint was also met in patients with immune-mediated necrotizing myopathy, while dermatomyositis patients showed a similar improvement, although it did not reach statistical significance.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IE0002141913.USD","IBB","IE00B4R5TH58.HKD","LU2324357040.USD","BK4585","BK4505","FMED","ARGX","BK4139","LU0889565916.HKD","IE0009355771.USD","TBXU","IE00BFTCPJ56.SGD","LU0320765992.SGD","IE00B2B36J28.USD","IE00BJJMRZ35.SGD","LU0109394709.USD","BK4588","LU1983260115.SGD","IE00BJT1NW94.SGD","LU0823416689.USD","IE0034235188.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":4,"totalSize":200,"code":"91000000","status":"200"}]}}